Skip to main content

Table 1 Demographic and clinical characteristics of 20 subjects diagnosed with BPD completing a 12-week trial with YGS

From: Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study

Sociodemographic and clinical variables Value
Sex, N (male/female) 22/18
Age, mean±SD, years 22.7 ± 7.3
IQ 88.9 ± 7.3